EP Patent

EP0163178A2 — Pharmaceutical composition

Assigned to Beecham Group PLC · Expires 1985-12-04 · 40y expired

What this patent protects

A pharmaceutical composition comprising a freely flowable powder, the powder comprising a porous, high absorption silica or silicate having absorbed therein at least 10% by volume of a liquid, pharmaceutically active composition, based on the weight of powder plus liquid, provide…

USPTO Abstract

A pharmaceutical composition comprising a freely flowable powder, the powder comprising a porous, high absorption silica or silicate having absorbed therein at least 10% by volume of a liquid, pharmaceutically active composition, based on the weight of powder plus liquid, provided that when the liquid pharmaceutically active composition is a corticoid solution the silica or silicate has a mean particle size of at least 10µm in diameter.

Drugs covered by this patent

Patent Metadata

Patent number
EP0163178A2
Jurisdiction
EP
Classification
—
Expires
1985-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Beecham Group PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.